target – Communicable Diseases Research

Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway

Article

Published on 2023-01-302022-11-15
Journal: Journal of ethnopharmacology
[Category] 유전자 메커니즘, 진단,

[키워드] Activation acute lung injury ALI model alleviate analysis Analysis attenuate Baidu caused Cell cellular China component Component analysis components Compound COVID-19 COVID-19 patients demonstrated experiment experimental validation Formula in vivo increases in indicated Inflammation ingredient inhibited inhibiting Kyoto lung Lung injury material mechanism of action Mild molecular mechanism network network pharmacology NF-κB pathway NF-κB signaling NF-κB signaling pathway Obstructive Ontology p-NF-κB p65 pathway pharmacological predicted proinflammatory Proteins reduced syndrome target treat Treatment Xuanfei baidu formula.
[DOI] 10.1016/j.jep.2022.115833 PMC 바로가기

Application of a high-throughput quantitative PCR system for simultaneous monitoring of SARS-CoV-2 variants and other pathogenic viruses in wastewater

Article

Published on 2022-12-202022-11-15
Journal: The Science of the total environment
[Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제,

[키워드] acute respiratory syndrome Alpha variant analyzed application applied assays can be used collected Community coronavirus coronavirus disease COVID-19 delta variant demonstrated detect eight epidemiologically FIVE Health High-throughput qPCR highlighting increase Japan L452R labor-intensive likelihood Mie N501Y nine nucleotide nucleotide substitution pathogenic virus pathogenic viruses Pathogenic viruses, SARS-CoV-2 Patient PCR positive prevalent qPCR quantitative PCR quarantine reported RNA RT-qPCR SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 variant separated Surveillance target tested time-consuming Treatment virus viruses Volume wastewater Wastewater. Yokkaichi
[DOI] 10.1016/j.scitotenv.2022.158659 PMC 바로가기

Reverse transcriptase-free detection of viral RNA using Hemo Klentaq DNA polymerase

Article

Published on 2022-12-152022-11-15
Journal: Analytical biochemistry
[Category] COVID19(2023년), SARS, 치료기술, 치료제,

A novel statistical method predicts mutability of the genomic segments of the SARS-CoV-2 virus

Research Article

Published on 2022-12-132022-10-29
Journal: Qrb Discovery
[Category] COVID-19,

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach

Short communication

Published on 2022-12-012022-10-05
Journal: Biochemistry and Biophysics Reports
[Category] 신약개발,

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

Article

Published on 2022-12-012022-11-15
Journal: Biochimica et biophysica acta. Molecular basis of
[Category] COVID19(2023년), SARS, 진단,

SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays

Article

Published on 2022-12-012022-11-15
Journal: Diagnostic microbiology and infectious disease
[Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제,

Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein

엽산: SARS-CoV-2 뉴클레오캡시드 단백질에 대한 잠재적 억제제

Article

Published on 2022-12-012022-09-11
Journal: Pharmaceutical Biology
[Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료법,

[키워드] analysed Analysis antagonist antiviral effects antivirus association cellular Chinese Chinese medicine Compound Concentration coronavirus disease Coronavirus disease 2019 COVID-19 Data analysis docking drug target experiment Folic acid Genes global pandemic Host hub genes identify inhibit inhibition inhibitor involved material mCherry mCherry expression mechanism molecular molecular docking network pharmacology Network pharmacology. Nucleocapsid phosphoprotein Phosphoprotein Protein Regulatory RNA interference RNAi SARS-CoV-2 SARS-CoV-2 N SARS-CoV-2 nucleocapsid screened shown target targets therapeutic target Traditional Traditional Chinese medicine virus
[DOI] 10.1080/13880209.2022.2063341 PMC 바로가기 [Article Type] Article

Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis

Article

Published on 2022-12-012022-11-15
Journal: Drug Delivery
[Category] COVID19(2023년), SARS, 치료제,

Epistasis-Driven Evolution of the SARS-CoV-2 Secondary Structure

Article

Published on 2022-12-012022-11-16
Journal: Journal of molecular evolution
[Category] COVID19(2023년), SARS, 변종,